A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

Children's National Medical Center - Department Of Neurology, Washington D.C.

UOC Neuropsichiatria Infantile, Istituto Neurologico Carlo Besta-Fondazione IRCCS, Milan

John Hopkins Medicine, Baltimore

Hospital Ruber Internacional, Neurology Department, Epilepsy Program, Madrid

Hospital Universitario 12 de Octubre, Madrid

CHU de Montpellier - Hôpital Gui de Chauliac - Département de neuropédiatrie, Montpellier

Akron Children's Hospital, Akron

CHU d'Angers - Service de génétique, Angers

Children's of Minnesota, Minneapolis

CHU de Strasbourg - Hôpital de Hautepierre - Service de Neuropédiatrie, Strasbourg

A.P.H.P - Hôpital Necker-Enfants Malades - Service de Neurologie pédiatrique, Paris

Baylor College of Medicine, Houston

University of Texas Health Science, Houston

University of California, San Diego

Stanford University, Stanford

Seattle Children's hospital, Seattle

Yale School of Medicine, New Haven

Pediatric Genetics Clinic (Main MGH Hospital), Boston

Boston Children Hospital, Boston

Alberta Children's Hospital, University of Calgary, Calgary

U.O.C. Malattie Muscolari e Neurodegenerative, Dipartimento di Scienze Neurologiche e Psichiatriche, Ospedale Pediatrico Bambino Gesù, Roma

PTC Clinical Site, Multiple Locations

Instytut Pomnik-Centrum Zdrowia Dziecka, Centrum Wsparacia Pediatrycznych Badań Klinicznych, Warsaw

Hospital Sant Joan de Déu, Barcelona

Karolinska University hospital, Astrid Lindgrens Children Hospital, Stockholm

Great Ormond Street Hospital for Children NHS Foundation Trust, London

The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne